--- title: "Bell Potter Sticks to Its Buy Rating for Pro Medicus Limited (PMCUF)" type: "News" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/275820639.md" description: "Bell Potter analyst John Hester has maintained a Buy rating for Pro Medicus Limited (PMCUF) with a price target of A$240.00. Hester, who focuses on the Healthcare sector, has an average return of 11.9% and a 50.00% success rate on his recommendations. Additionally, Jefferies analyst Jennifer Xu also issued a Buy rating for Pro Medicus today, while TipRanks reiterated a Hold rating on February 10." datetime: "2026-02-12T22:35:32.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/275820639.md) - [en](https://longbridge.com/en/news/275820639.md) - [zh-HK](https://longbridge.com/zh-HK/news/275820639.md) --- > 支持的語言: [简体中文](https://longbridge.com/zh-CN/news/275820639.md) | [English](https://longbridge.com/en/news/275820639.md) # Bell Potter Sticks to Its Buy Rating for Pro Medicus Limited (PMCUF) Bell Potter analyst John Hester maintained a Buy rating on Pro Medicus Limited today and set a price target of A$240.00. ### Valentine's Day Sale - 70% Off - Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions - Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential Hester covers the Healthcare sector, focusing on stocks such as Mesoblast Limited, Aroa Biosurgery Ltd, and Radiopharm Theranostics Limited. According to TipRanks, Hester has an average return of 11.9% and a 50.00% success rate on recommended stocks. In addition to Bell Potter, Pro Medicus Limited also received a Buy from Jefferies’s Jennifer Xu in a report issued today. However, on February 10, TipRanks – OpenAI reiterated a Hold rating on Pro Medicus Limited (Other OTC: PMCUF). ### 相關股票 - [Pro Medicus Limited (PME.AU)](https://longbridge.com/zh-HK/quote/PME.AU.md) ## 相關資訊與研究 - [09:01 ETVisage Elevates AI Optimized Enterprise Imaging at HIMSS26](https://longbridge.com/zh-HK/news/278562163.md) - [Pro Medicus H1 Profit, Revenue Climb](https://longbridge.com/zh-HK/news/275712482.md) - [Macquarie Keeps Their Buy Rating on Ampol Limited (CTXAF)](https://longbridge.com/zh-HK/news/281086918.md) - [Canaccord Genuity Sticks to Its Buy Rating for EQ Resources Limited (EQR)](https://longbridge.com/zh-HK/news/281461759.md) - [Ord Minnett Keeps Their Hold Rating on Macmahon Holdings Limited (MCHHF)](https://longbridge.com/zh-HK/news/281112235.md)